Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Natera Inc (NTRA)

Natera Inc (NTRA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Natera Announces Pricing of Follow-On Offering

Natera, Inc. (Nasdaq: NTRA), a global leader in cell-free DNA testing, today announced the pricing of its underwritten public offering of 5,714,286 shares of its common stock at a price to the public of...

NTRA : 37.55 (-5.80%)
After Yesterday's Decline of 7.92%, Natera Inc Offers Investors Better Value

Natera Inc (NASDAQ:NTRA) traded in a range yesterday that spanned from a low of $34.86 to a high of $37.85. Yesterday, the shares fell 7.9%, which took the trading range below the 3-day low of $35.92...

NTRA : 37.55 (-5.80%)
Natera Launches Proposed Follow-On Offering

Natera, Inc. (Nasdaq: NTRA), a global leader in cell-free DNA testing, today announced the launch of a proposed follow-on public offering of $175,000,000 of shares of its common stock. In addition, Natera...

NTRA : 37.55 (-5.80%)
Insmed Inc has the Best Relative Performance in the Biotechnology Industry (INSM , ALKS , NTRA , ESPR , CYTK )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

ALKS : 18.42 (+0.05%)
INSM : 18.23 (-0.11%)
NTRA : 37.55 (-5.80%)
Shares of Natera Inc Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (NTRA , IONS , ALXN , CARA , CTMX )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

ALXN : 99.24 (-1.48%)
IONS : 54.74 (-0.94%)
NTRA : 37.55 (-5.80%)
Pfenex Inc has the Best Relative Performance in the Biotechnology Industry (PFNX, HRTX , NTRA , FLXN , ARWR)

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

HRTX : 18.58 (-2.42%)
NTRA : 37.55 (-5.80%)
PFNX : 9.20 (-0.65%)
ARWR : 38.96 (+6.74%)
Natera Reaches Analyst Target Price

In recent trading, shares of Natera Inc have crossed above the average analyst 12-month target price of $35.40, changing hands for $35.47/share. When a stock reaches the target an analyst has set, the...

NTRA : 37.55 (-5.80%)
Best Relative Performance in the Biotechnology Industry Detected in Shares of Sarepta Therapeu (SRPT , NTRA , CHRS , BLUE , PTCT )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

CHRS : 18.61 (-2.97%)
NTRA : 37.55 (-5.80%)
SRPT : 85.53 (-1.26%)
SmarTrend Watching for Potential Pullback in Shares of Natera Inc After 3.99% Gain

Natera Inc (NASDAQ:NTRA) traded in a range yesterday that spanned from a low of $33.41 to a high of $34.90. Yesterday, the shares gained 4.0%, which took the trading range above the 3-day high of $34.04...

NTRA : 37.55 (-5.80%)
Natera to Host Investor Conference Call to Discuss Progress in its Oncology Business

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced it will review recent progress in its oncology business, including the positive draft local coverage decision for...

NTRA : 37.55 (-5.80%)
Natera (NTRA) Scales 52-Week High: What's Driving the Stock?

Natera (NTRA) is likely to maintain the current high on a number of favorable factors.

GWPH : 124.43 (+2.43%)
CAPR : 2.67 (+2.30%)
NTRA : 37.55 (-5.80%)
NTRP : 0.66 (-1.49%)
Foundation Medicine and Natera Partner to Advance Personalized Cancer Monitoring

Foundation Medicine, Inc. and Natera, Inc. (NASDAQ: NTRA) today announced a partnership to develop and commercialize personalized circulating tumor DNA (ctDNA) monitoring assays, for use by biopharmaceutical...

FMI : 136.95 (-0.04%)
NTRA : 37.55 (-5.80%)
Foundation Medicine and Natera Partner to Advance Personalized Cancer Monitoring

Foundation Medicine, Inc. and Natera, Inc. (NASDAQ: NTRA) today announced a partnership to develop and commercialize personalized circulating tumor DNA (ctDNA) monitoring assays, for use by biopharmaceutical...

FMI : 136.95 (-0.04%)
NTRA : 37.55 (-5.80%)
CBR® Acquires Evercord(TM) Newborn Stem Cell Business from Natera

CBR (Cord Blood Registry), the world's largest newborn stem cell collection and storage company, today announced the asset acquisition of Natera, Inc.'s (NASDAQ: NTRA) Evercord(TM) newborn stem cell business....

NTRA : 37.55 (-5.80%)
CBR to Acquire Natera's Evercord(TM) Cord Blood Business

Natera, Inc. (NASDAQ: NTRA) and CBR (Cord Blood Registry) today announced the acquisition by CBR, a California Cryobank Life Sciences company, and the world's largest newborn stem cell collection and storage...

NTRA : 37.55 (-5.80%)
Natera Inc Up 101.7% Since SmarTrend Uptrend Call (NTRA)

SmarTrend identified an Uptrend for Natera Inc (NASDAQ:NTRA) on February 11th, 2019 at $14.87. In approximately 7 months, Natera Inc has returned 101.75% as of today's recent price of $30.00.

NTRA : 37.55 (-5.80%)
Natera Publishes Largest NIPT Outcomes Study Demonstrating Robust Clinical Performance Over a 4-year Period

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced the publication of the largest non-invasive prenatal test (NIPT) outcomes study to date, analyzing its Panorama®...

NTRA : 37.55 (-5.80%)
Natera to Present at the Morgan Stanley 17th Annual Global Healthcare Conference

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced it will webcast a live presentation at the Morgan Stanley 17th Annual Global Healthcare Conference at the Grand Hyatt...

MS : 45.38 (+0.89%)
NTRA : 37.55 (-5.80%)
Natera Appoints Rowan Chapman to its Board of Directors

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, has appointed Rowan Chapman, Ph.D., to its board of directors, effective August 15, 2019.

NTRA : 37.55 (-5.80%)
Natera to Webcast Live Presentation at the Baird 2019 Global Healthcare Conference

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced it will webcast a live presentation at the Baird 2019 Global Healthcare Conference at the InterContinental New York...

NTRA : 37.55 (-5.80%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI -2.04 , AIZ -1.29 , SBAC -0.82 , SO -0.14 , WELL -0.29
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar